Evidence map›Paper›PMID 33376961›Full record

ArticleJAMIA open2020

Using indication embeddings to represent patient health for drug safety studies.

Rachel D Melamed

Open access · goldAbstract read
In one paragraph

Article in JAMIA open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Hierarchical Concept Relations Improve Detection of Off-Label Drug Use in Electronic Health Records Data.AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science · 2023
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Rachel D MelamedDepartment of Biological Sciences, University of Massachusetts, Lowell, 198 Riverside St, Lowell, Massachusetts, USA.ORCID 0000-0003-3089-9806
University of Massachusetts Lowell · US

Funding

Using clinical data to identify FDA-approved drugs for cancer prevention and therapeutic repurposingK01ES028055 · NIEHS · UNIVERSITY OF MASSACHUSETTS LOWELL · PI MELAMED, RACHEL DANIA · 2017 to 2020
$500k
NIEHS NIH HHS K01 ES028055
6 · The paper itself

Abstract

objectiveThe electronic health record is a rising resource for quantifying medical practice, discovering the adverse effects of drugs, and studying comparative effectiveness. One of the challenges of applying these methods to health care data is the high dimensionality of the health record. Methods to discover the effects of drugs in health data must account for tens of thousands of potentially relevant confounders. Our goal in this work is to reduce the dimensionality of the health data with the aim of accelerating the application of retrospective cohort studies to this data. MATERIALS AND

methodsHere, we develop indication embeddings, a way to reduce the dimensionality of health data while capturing information relevant to treatment decisions. We evaluate these embeddings using external data on drug indications. Then, we use the embeddings as a substitute for medical history to match patients and develop evaluation metrics for these matches.

resultsWe demonstrate that these embeddings recover the therapeutic uses of drugs. We use embeddings as an informative representation of relationships between drugs, between health history events and drug prescriptions, and between patients at a particular time in their health history. We show that using embeddings to match cohorts improves the balance of the cohorts, even in terms of poorly measured risk factors like smoking. DISCUSSION AND

conclusionUnlike other embeddings inspired by word2vec, indication embeddings are specifically designed to capture the medical history leading to the prescription of a new drug. For retrospective cohort studies, our low-dimensional representation helps in finding comparator drugs and constructing comparator cohorts.

Indexed as

causal inferencecohort studiesdimensionality reductionembeddingsrepresentation

Identifiers

PMID33376961
PMCPMC7751136
OpenAlexW3096444831

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.